Sergey Kulemzin
Sergey Kulemzin
Researcher, Institute of Molecular and Cellular Biology SB RAS
Подтвержден адрес электронной почты в домене mcb.nsc.ru
Название
Процитировано
Процитировано
Год
Evasion of the innate immune response: the Old World alphavirus nsP2 protein induces rapid degradation of Rpb1, a catalytic subunit of RNA polymerase II
I Akhrymuk, SV Kulemzin, EI Frolova
Journal of virology 86 (13), 7180-7191, 2012
1522012
FCRLA is a resident endoplasmic reticulum protein that associates with intracellular Igs, IgM, IgG and IgA
T Santiago, SV Kulemzin, ES Reshetnikova, NA Chikaev, OY Volkova, ...
International immunology 23 (1), 43-53, 2011
292011
FCRL6 receptor: Expression and associated proteins
SV Kulemzin, AY Zamoshnikova, MY Yurchenko, NY Vitak, AM Najakshin, ...
Immunology letters 134 (2), 174-182, 2011
132011
VEGFR2-specific FnCAR effectively redirects the cytotoxic activity of T cells and YT NK cells
SV Kulemzin, AA Gorchakov, AN Chikaev, VV Kuznetsova, OY Volkova, ...
Oncotarget 9 (10), 9021, 2018
82018
Engineering Chimeric Antigen Receptors
SV Kulemzin, VV Kuznetsova, M Mamonkin, AV Taranin
Acta Naturae (англоязычная версия) 9 (1 (32)), 2017
82017
CAR T-cell therapy: Balance of efficacy and safety
SV Kulemzin, VV Kuznetsova, M Mamonkin, AV Taranin, AA Gorchakov
Molecular Biology 51 (2), 237-250, 2017
62017
Design and analysis of stably integrated reporters for inducible transgene expression in human T cells and CAR NK-cell lines
SV Kulemzin, DA Matvienko, AH Sabirov, AM Sokratyan, DS Chernikova, ...
BMC medical genomics 12 (2), 44, 2019
42019
Modular lentiviral vector system for chimeric antigen receptor design optimization
SV Kulemzin, NA Chikaev, OY Volkova, VV Kuznetsova, AV Taranin, ...
Russian Journal of Bioorganic Chemistry 43 (2), 107-114, 2017
32017
Development and Characterization of Domain-Specific Monoclonal Antibodies Produced Against Human SLAMF9
O Volkova, S Guselnikov, L Mechetina, N Chikaev, K Baranov, ...
Monoclonal antibodies in immunodiagnosis and immunotherapy 33 (4), 209-214, 2014
32014
Characterization of human FCRLA isoforms
S Kulemzin, N Chikaev, O Volkova, E Reshetnikova, A Taranin, ...
Immunology letters 152 (2), 153-158, 2013
32013
Challenges and Prospects of Chimeric Antigen Receptor T-cell Therapy for Metastatic Prostate Cancer
AA Gorchakov, SV Kulemzin, GV Kochneva, AV Taranin
European Urology, 2019
22019
ECAR-NK Cell Platform: Enhancing the CAR-Mediated NK Cell Cytotoxicity via Blockade of the CD47/SIRPa Axis
A Gorchakov, AN Chikaev, SV Kulemzin, OY Volkova, DS Chernikova, ...
MOLECULAR THERAPY 26 (5), 199-199, 2018
12018
Analysis of in vitro activity of PSCA-spe-cific CARs in the context of human NK cell line YT
DA Matvienko, SV Kulemzin, AS Smagina, TN Belovezhets, AN Chikaev, ...
Cellular Therapy and Transplantation 7 (2), 70-77, 2018
12018
Comparative analysis of lactaptin activity when produced in bacterial or eukaryotic expression systems
OA Koval, OY Volkova, AA Gorchakov, SV Kulemzin, AV Tkachenko, ...
Vavilovskii Zhurnal Genetiki i Selektsii 21 (7), 764-769, 2017
12017
FCRLA is an intracellular FcR-related protein that binds IgM, IgG and IgA isotypes in B cells (45.11)
P Burrows, T Santiago, S Kulemzin, E Reshetnikova, N Chikaev, ...
The Journal of Immunology 186 (1 Supplement), 45.11-45.11, 2011
12011
Combination of Oncolytic Virotherapy and CAR T/NK Cell Therapy for the Treatment of Cancer
GV Kochneva, GF Sivolobova, AV Tkacheva, AA Gorchakov, SV Kulemzin
Molecular Biology 54 (1), 1-12, 2020
2020
A simple way to increase recovery of the expressed VH and VL genes in single-sorted human B cells
SV Guselnikov, TN Belovezhets, SV Kulemzin, AA Gorchakov, AV Taranin
BioTechniques 67 (4), 184-187, 2019
2019
Anti-Idiotypic Monoclonal Antibodies Targeting the Germline Variant of a Broadly Neutralizing HIV-Specific Antibody VRC01
AA Gorchakov, OY Volkova, KO Baranov, DS Chernikova, LV Mechetina, ...
MOLECULAR THERAPY 27 (4), 143-144, 2019
2019
Prostate cancer surface targets for CAR T cell therapy or metastatic prostate cancer in the CAR T cell era: My kingdom for the target!
SV Kulemzin, AA Gorchakov, AV Taranin
Cellular Therapy and Transplantation 8 (4), 19-28, 2019
2019
36P CAR-modified natural killer cell line expressing CD47/SIRPa blockers as a combined approach for solid cancer therapy
A Chikaev, A Gorchakov, S Kulemzin, T Belovezhets, D Matvienko, ...
Annals of Oncology 29 (suppl_10), mdy485. 005, 2018
2018
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20